Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Arquivos Brasileiros De Endocrinologia E Metabologia|February 4, 2010
Targeted molecular therapies in thyroid carcinomaSerena Romagnoli, Sonia Moretti, Pasquale Voce, et al.
Frontiers in Endocrinology|June 5, 2012
Intracellular signal transduction and modification of the tumor microenvironment induced by RET/PTCs in papillary thyroid carcinomaElisa Menicali, Sonia Moretti, Pasquale Voce, et al.
Thyroid : Official Journal of the American Thyroid Association|December 24, 2011
Sunitinib exerts only limited effects on the proliferation and differentiation of anaplastic thyroid cancer cellsMaria D'Agostino, Pasquale Voce, Marilena Celano, et al.
Oncology Reports|August 19, 2011
Sunitinib inhibits tumor vascularity and growth but does not affect Akt and ERK phosphorylation in xenograft tumorsPasquale Voce, Maria D'Agostino, Sonia Moretti, et al.
Biomaterials|May 20, 2014
Targeting the thyroid gland with thyroid-stimulating hormone (TSH)-nanoliposomesDonatella Paolino, Donato Cosco, Marco Gaspari, et al.
The Journal of Biological Chemistry|December 21, 2016
Signal Transducer and Activator of Transcription 1 Plays a Pivotal Role in RET/PTC3 Oncogene-induced Expression of Indoleamine 2,3-Dioxygenase 1Sonia Moretti, Elisa Menicali, Nicole Nucci, et al.
The Journal of Clinical Endocrinology and Metabolism|February 13, 2014
Indoleamine 2,3-dioxygenase 1 (IDO1) is up-regulated in thyroid carcinoma and drives the development of an immunosuppressant tumor microenvironmentSonia Moretti, Elisa Menicali, Pasquale Voce, et al.
Pageof 1